Kater AP, Jiang Y, Chyla B, Seymour JF. Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab. Haematologica 2020; 105(7):e382-e383; https://doi.org/10.3324/haematol.2020.253849.